Kunyong Yang's practice focuses on developing and managing global patent portfolios involving pharmaceutical, chemical, and biotechnology innovations, including small molecule drugs, lipid nanoparticles, antibody drug conjugates, radiopharmaceuticals, and chemical modification of oligonucleotides (e.g., siRNA, mRNA). He guides clients from the early stages of patent portfolio development, through the product development process, to the development of late-stage life cycle management strategies and regulatory extension opportunities. Particular small molecule pharmaceuticals that Kunyong has been involved with include REVLIMID® (lenalidomide), ONUREG® (azacitidine tablets), ALUNBRIG® (brigatinib), iberdomide, mezigdomide, golcadomide, zidesamtinib, duvelisib, and eganelisib.
Kunyong also advises clients on due diligence matters, including providing patentability, validity, and freedom-to-operate analysis, in association with clients' investment in or acquisition of third parties, as well as licensing and collaboration opportunities. In addition, Kunyong has experience in Hatch-Waxman litigation and patent post-grant proceedings, including inter partes review (IPR) and post-grant review (PGR).
Representative clients include BMS/Celgene, AbbVie, Merck, Nuvalent, HUA Medicine, and Suzhou Abogen Biosciences Co.
Prior to joining Jones Day, Kunyong worked at the Genomics Institute of the Novartis Research Foundation as a medicinal chemist.
经验
- January 18, 2024
Foreign Filing Licenses and Other Issues Related to Cross-pacific Patent Inventions - November 9, 2022
Advancing Global Drug Development, East-West Biopharma Summit Road Trip - May 19, 2022
Inventorship and Inventor Interviews for U.S. Patent Application Drafting - November 18, 2021
Interplay between Regulatory and Patent Exclusivities – Strategic Considerations
__PRESENT
- University of San Diego (J.D. magna cum laude 2013; Order of the Coif; Member, San Diego Law Review); Michigan Technological University (Master's in Organic Chemistry 2002); Nanjing University, China (B.S. in Chemistry with honors 1998)
- California and registered to practice before the U.S. Patent and Trademark Office
- Chinese (Mandarin)
发送前请注意
*Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice